RecruitingNCT05907681
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Sponsor
Samsung Medical Center
Enrollment
400 participants
Start Date
May 11, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Eligibility
Sex: FEMALEMin Age: 19 YearsMax Age: 100 Years
Plain Language Summary
Simplified for easier understanding
This is an observational study (no experimental treatment is given) tracking the real-world outcomes of metastatic breast cancer patients who are receiving high-precision radiation therapy. The aim is to better understand how this type of radiation works in patients whose cancer has spread.
**You may be eligible if...**
- You have breast cancer that has spread to other parts of the body (metastatic)
- You are receiving or planning to receive precision radiation therapy (IMRT, SBRT, or proton therapy)
- You are willing and able to follow the study protocol
**You may NOT be eligible if...**
- You are unable to follow the study protocol
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05907681
Related Trials
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
NCT049373098 locations
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
NCT048999082 locations
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
NCT0512348267 locations
Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
NCT0699437737 locations
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
NCT046141942 locations